Sandbox g25: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "<div style="-webkit-user-select: none;"> {|class="infobox" style="position: fixed; top: 183px; right: 20px; margin: 0 0 0 0; border: 0; float: right; width: 19%; background: #...")
 
mNo edit summary
Line 5: Line 5:
|-
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Adult Indications and Dosage|{{fontcolor|#FFFFFF|Adult Indications & Dosage}}]]
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Adult Indications and Dosage|{{fontcolor|#FFFFFF|Adult Indications & Dosage}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Pediatric Indications and Dosage|{{fontcolor|#FFFFFF|Pediatric Indications & Dosage}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Contraindications|{{fontcolor|#FFFFFF|Contraindications}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Warnings|{{fontcolor|#FFFFFF|Warnings & Precautions}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Adverse Reactions|{{fontcolor|#FFFFFF|Adverse Reactions}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Drug Interactions|{{fontcolor|#FFFFFF|Drug Interactions}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Use in Specific Populations|{{fontcolor|#FFFFFF|Use in Specific Populations}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Administration and Monitoring|{{fontcolor|#FFFFFF|Administration & Monitoring}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Overdosage|{{fontcolor|#FFFFFF|Overdosage}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Pharmacology|{{fontcolor|#FFFFFF|Pharmacology}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Clinical Studies|{{fontcolor|#FFFFFF|Clinical Studies}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#How Supplied|{{fontcolor|#FFFFFF|How Supplied}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Images|{{fontcolor|#FFFFFF|Images}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Patient Counseling Information|{{fontcolor|#FFFFFF|Patient Counseling Information}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Precautions with Alcohol|{{fontcolor|#FFFFFF|Precautions with Alcohol}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Brand Names|{{fontcolor|#FFFFFF|Brand Names}}]]
|-
| style="font-size: 10px; padding: 1.5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5); font-weight: bold;" | [[{{PAGENAME}}#Look-Alike Drug Names|{{fontcolor|#FFFFFF|Look-Alike Names}}]]
|}
|}
</div>
</div>

Revision as of 06:35, 7 June 2015

Sandbox g25
Adult Indications & Dosage


  ▸  Group criteria
❑ Patients who do not have warning signs
PLUS
❑ Able to tolerate adequate volumes of oral fluids
OR
❑ Able to pass urine at least once every 6 hours
  ▸  Laboratory tests
❑ Complete blood count
❑ Hematocrit (Hct)
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_g25&oldid=1106481"